← Back to Search

symptomatic acute pulpitis for Acute Pulpitis

N/A
Recruiting
Research Sponsored by Cleveland Dental Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Summary

The aim of the proposed study is to investigate and comprehensively understand pain perception in patients diagnosed with symptomatic acute pulpitis who are resistant to inferior alveolar nerve block (IANB). The study aims to achieve this by utilizing a dual approach that combines subjective self-reporting of pain intensity using the Numeric Rating Scale (NRS) with objective neurophysiological assessment through brain wave analysis using electroencephalography (EEG). By integrating these two methods, the study seeks to explore potential correlations between self-reported pain scores and neural responses recorded through EEG, providing insights into the pain experience of this specific patient population. Ultimately, the goal of the study is to enhance the understanding of pain perception mechanisms in individuals with symptomatic acute pulpitis resistant to IANB and potentially guide the development of more effective and personalized pain management strategies for these patients.

Eligible Conditions
  • Acute Pulpitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Electroencephalography (EEG)
Numerical Rate Scale (NRS)

Trial Design

1Treatment groups
Experimental Treatment
Group I: symptomatic acute pulpitisExperimental Treatment2 Interventions
Patients with symptomatic acute pulpitis who are resistant to inferior alveolar nerve block (IANB)

Find a Location

Who is running the clinical trial?

Cleveland Dental InstituteLead Sponsor
5 Previous Clinical Trials
392 Total Patients Enrolled
Ahmed A hashem, PhDStudy DirectorCDI
~3 spots leftby Oct 2024